Osh .
About Osh .
Osh is the Founder, CEO, and CTO of Koniku, where he leads a multidisciplinary team focused on synthetic neurobiology. He has a strong academic background in physics and computational neuroscience, with previous experience at ETH Zürich and Imperial College London.
Work at Koniku
Osh has served as the Founder, CEO, and CTO of Koniku since 2015. Under his leadership, the company focuses on synthetic neurobiology, aiming to develop innovative solutions for various sectors, including healthcare, security, defense, food, and environmental challenges. Osh leads a multidisciplinary team composed of engineers, biologists, and neuroscientists, fostering collaboration to push the boundaries of technology in neurobiology.
Education and Expertise
Osh has an extensive educational background in physics and neuroscience. He studied at the University of Lagos, where he earned a Bachelor of Science in Theoretical and Mathematical Physics. He then pursued a Master of Science in Physics at Umeå University. Osh continued his studies at ETH Zürich, achieving a degree in Physics, followed by a Doctoral program. He further advanced his expertise at Imperial College London, where he completed a degree in Computational Neuroscience and Engineering.
Background
Osh's academic journey began at the Federal College of Fisheries and Marine Technology, where he studied Naval Architecture and Marine Engineering. He then transitioned to theoretical and mathematical physics, culminating in a robust foundation in physics and neuroscience. Prior to his role at Koniku, he worked as a PhD candidate and research assistant at Imperial College London, contributing to significant research in the field.
Achievements
Osh has a history of involvement in startups with successful exits, notably Neuronics AG in Zurich. His research contributions include the development of an in vitro reflex arc for modeling implantable neural chips and the construction of customized two-photon microscopes for studying synaptic transmission in the mouse visual cortex. These projects highlight his commitment to advancing the field of synthetic neurobiology.